The U.S. Food and Drug Administration has approved a CBD drug – a landmark decision that will trigger the health agency to seek rescheduling from the DEA.
FDA approves cannabis-derived medicine; DEA must weigh in is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: FDA approves cannabis-derived medicine; DEA must weigh in
Comments are closed, but trackbacks and pingbacks are open.